Journal of Commercial Biotechnology — January 2010 issue now available

Journal of Commercial Biotechnology — January 2010 issue now available

The January 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 16, Issue 1

Editorial

Time for a new business model? PDF
Yali Friedman

Commentary

Why data exclusivity is the new patent protection PDF
Peter J Pitts
Follow-on biologic drug competition – No need for new marketing exclusivities PDF
Michael S Wroblewski, Elizabeth A Jex

Articles

Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb PDF
Nigel Borshell, Adrian Dawkes
Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms PDF
Mark J Ahn, Michael Meeks, Sally Davenport, Rebecca Bednarek
Intellectual property landscape and patenting opportunity in biofuels PDF
Ramasamy Mannan
Challenges and opportunities in the licensing of renewable technologies PDF
Meredith Lloyd-Evans, Mike Gilbert, Ilian P Iliev
Ethiopia: Biotechnology for development PDF
Desta Berhe Sbhatu
Innovation and commercialisation in the stem cell industries in Australia: State strategies and other opportunities to build a competitive position in the global stem cell economy PDF
Olivia Harvey

Legal and Regulatory Updates

Using IP audits to optimize IP assets PDF
James G Cullem

Book Reviews

Book Review: Health-care investing: Profiting from the new world of pharma, biotech and health-care services PDF
Frank LaSaracina
Book Review: Aging, Biotechnology, and the Future PDF
Harley King

1 COMMENT

Leave a Reply